Results 31 to 40 of about 5,165,410 (355)

Texture analysis of aggressive and nonaggressive lung tumor CE CT images [PDF]

, 2008
This paper presents the potential for fractal analysis of time sequence contrast-enhanced (CE) computed tomography (CT) images to differentiate between aggressive and nonaggressive malignant lung tumors (i.e., high and low metabolic tumors).
Al-Kadi, Omar S, Watson, D
core   +1 more source

Current advance of nanotechnology in diagnosis and treatment for malignant tumors

Signal Transduction and Targeted Therapy
Cancer remains a significant risk to human health. Nanomedicine is a new multidisciplinary field that is garnering a lot of interest and investigation. Nanomedicine shows great potential for cancer diagnosis and treatment.
Bilan Wang, Shiqi Hu, Yan Teng, Junli Chen, Haoyu Wang, Yezhen Xu, Kaiyu Wang, Jianguo Xu, Yongzhong Cheng, Xiang Gao   +9 more
semanticscholar   +1 more source

Benign and malignant tumors in Rubinstein–Taybi syndrome

American Journal of Medical Genetics. Part A, 2018
Rubinstein–Taybi syndrome (RSTS) is a multiple congenital anomalies syndrome associated with mutations in CREBBP (70%) and EP300 (5–10%). Previous reports have suggested an increased incidence of specific benign and possibly also malignant tumors.
Max V Boot, M. V. van Belzen, L. Overbeek, N. Hijmering, Matias Mendeville, Q. Waisfisz, P. Wesseling, R. Hennekam, D. de Jong   +8 more
semanticscholar   +1 more source

MRI-Based Radiomics Nomogram: Prediction of Axillary Non-Sentinel Lymph Node Metastasis in Patients With Sentinel Lymph Node-Positive Breast Cancer

Frontiers in Oncology, 2022
BackgroundOvertreatment of axillary lymph node dissection (ALND) may occur in patients with axillary positive sentinel lymph node (SLN) but negative non-SLN (NSLN).
Ya Qiu, Ya Qiu, Ya Qiu, Xiang Zhang, Xiang Zhang, Zhiyuan Wu, Shiji Wu, Shiji Wu, Shiji Wu, Zehong Yang, Zehong Yang, Dongye Wang, Dongye Wang, Hongbo Le, Hongbo Le, Jiaji Mao, Jiaji Mao, Guochao Dai, Xuwei Tian, Renbing Zhou, Jiayi Huang, Jiayi Huang, Lanxin Hu, Lanxin Hu, Jun Shen, Jun Shen   +25 more
doaj   +1 more source

Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors

Frontiers in Oncology, 2023
BackgroundThe 5th edition of the World Health Organization (WHO) classification of central nervous system tumors incorporated specific molecular alterations into the categorization of gliomas.
Xiaopeng Guo, Xiaopeng Guo, Yixin Shi, Yixin Shi, Delin Liu, Delin Liu, Yilin Li, Yilin Li, Wenlin Chen, Yaning Wang, Yuekun Wang, Hao Xing, Yu Xia, Yu Xia, Junlin Li, Junlin Li, Jiaming Wu, Jiaming Wu, Tingyu Liang, Hai Wang, Qianshu Liu, Qianshu Liu, Shanmu Jin, Shanmu Jin, Tian Qu, Tian Qu, Siying Guo, Siying Guo, Huanzhang Li, Huanzhang Li, Tianrui Yang, Tianrui Yang, Kun Zhang, Kun Zhang, Yu Wang, Yu Wang, Wenbin Ma, Wenbin Ma   +37 more
doaj   +1 more source

Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients. [PDF]

, 2014
BackgroundGender-based differences in disease onset in murine models of malignant peripheral nerve sheath tumor (MPNST) and in patients with Neurofibromatosis type-1-(NF-1)-associated or spontaneous MPNST has not been well studied.MethodsForty-three ...
Dry, Sarah M, Eilber, Fritz C, Federman, Noah, Li, Yunfeng, Nakashima, Jonathan, Shurell, Elizabeth, Smith, Kathleen B, Tam, Brenna M, Tap, William D, Tran, Linh M, Wu, Hong   +10 more
core   +2 more sources

Differentiating benign from malignant cardiac tumors with cardiac magnetic resonance imaging

Journal of Thoracic and Cardiovascular Surgery, 2019
Background: The purpose of this analysis is to describe the differences in cardiac magnetic resonance characteristics between benign and malignant tumors, which would be helpful for surgical planning.
M. Kassi, V. Polsani, R. Schutt, Solomon Wong, F. Nabi, M. Reardon, D. Shah   +6 more
semanticscholar   +1 more source

Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumors

Frontiers in Oncology, 2023
IntroductionGlioblastoma (GBM), the most lethal primary brain malignancy, is divided into histological (hist-GBM) and molecular (mol-GBM) subtypes according to the 2021 World Health Organization classification of central nervous system tumors. This study
Xiaopeng Guo, Xiaopeng Guo, Lingui Gu, Yilin Li, Yilin Li, Zhiyao Zheng, Zhiyao Zheng, Zhiyao Zheng, Wenlin Chen, Yaning Wang, Yuekun Wang, Hao Xing, Yixin Shi, Yixin Shi, Delin Liu, Delin Liu, Tianrui Yang, Tianrui Yang, Yu Xia, Yu Xia, Junlin Li, Junlin Li, Jiaming Wu, Jiaming Wu, Kun Zhang, Kun Zhang, Tingyu Liang, Hai Wang, Qianshu Liu, Qianshu Liu, Shanmu Jin, Shanmu Jin, Tian Qu, Tian Qu, Siying Guo, Siying Guo, Huanzhang Li, Huanzhang Li, Yu Wang, Yu Wang, Wenbin Ma, Wenbin Ma   +41 more
doaj   +1 more source

TYK2 promotes malignant peripheral nerve sheath tumor progression through inhibition of cell death [PDF]

, 2019
BACKGROUND: Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas that arise most commonly in the setting of the Neurofibromatosis Type 1 (NF1) cancer predisposition syndrome.
Bu, Xianzhang, Godec, Abigail, Hirbe, Angela C, Qin, Wenjing, Shao, Jieya, Tao, Yu, Zhang, Xiaochun, Zhu, Cuige   +7 more
core   +2 more sources

Regression/eradication of gliomas in mice by a systemically-deliverable ATF5 dominant-negative peptide. [PDF]

, 2016
Malignant gliomas have poor prognosis and urgently require new therapies. Activating Transcription Factor 5 (ATF5) is highly expressed in gliomas, and interference with its expression/function precipitates targeted glioma cell apoptosis in vitro and in ...
Angelastro, James, Arias, Angelo, Cates, Charles, Cayanan, Geraldine, Fung, Jennifer, Greene, Lloyd, Karpel-Massler, Georg, Lamé, Michael, Nakayama Wong, Lynn, Rowland, Douglas, Sidorov, Maxim, Siegelin, Markus   +11 more
core   +2 more sources